Komori
Changes in Officers4549EIKEN CHEMICAL CO.,LTD.Pharmaceuticals

Notice Regarding Change in Representative Executive Officer

Notomi Tsugunori (納富 継宣), Director and Chairman, Representative Executive Officer, will retire upon expiration of his term on 23 June 2026. The successor is not specified in this document.

Worth reading
28Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Who is moving to which position

Resolved 12 May 2026

Departing officer

1 item
Date of departure23 June 2026
Natomi Tsugunori (納富 継宣)Stepping down
Former PositionDirector and Chairman, Representative Executive Officer
Reason for departure

Retirement upon expiration of the term of office

Whether the incumbent will remain in office (whether they will retain their position)

Whether he will remain on the Board of Directors: Not disclosed

Shareholders’ meeting approvalTo be formally decided by the Board of Directors after the 88th Annual General Meeting of Shareholders scheduled for 23 June 2026
Reason for change

Retirement upon expiration of the term of office

Who is moving to which position
ItemDetails
Resolution date12 May 2026
Date of departure23 June 2026
Name of departing officerNatomi Tsugunori (納富 継宣)
Former position of departing officerDirector and Chairman, Representative Executive Officer
Reason for departureRetirement upon expiration of the term of office
Whether the incumbent will remain in officeWhether he will remain on the Board of Directors: Not disclosed
Reason for changeRetirement upon expiration of the term of office
Subject to Approval by the General Meeting of ShareholdersTo be formally decided by the Board of Directors after the 88th Annual General Meeting of Shareholders scheduled for 23 June 2026
Items this document does not state (13)
Scheduled Appointment DateName of appointeeAppointee's new positionAppointee's previous positionAppointee's date of birthYear the appointee joined the CompanyNumber of shares held by the appointeeNew position of departing officerReasons for appointmentNumber of directors after the changeFiling as an independent officerDetails of organizational changesChange in Corporate Governance Structure

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Retirement upon expiration of the term of office

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding Change in Representative Executive Officer | EIKEN CHEMICAL CO.,LTD. (4549) timely disclosure | Komori